ROYALTY PHARMA PLC - CLASS A
ROYALTY PHARMA PLC - CLASS A
Share · GB00BMVP7Y09 · RPRX · A2P62D (XNAS)
Overview Financial Indicators
33,61 USD
0,64 % 0,21 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 18:35

Current Prices from ROYALTY PHARMA PLC - CLASS A

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
RPRX
USD
10.06.2025 18:36
33,61 USD
33,39 USD
+0,66 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,66 % -0,68 % 1,39 % 1,82 % 29,22 % 22,40 % -24,47 %

Company Profile for ROYALTY PHARMA PLC - CLASS A Share

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Invested Funds

The following funds have invested in: ROYALTY PHARMA PLC - CLASS A invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
511,18
Percentage (%)
1,20 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
324,74
Percentage (%)
0,09 %
Fund
iShares MSCI USA ESG Screened UCITS ETF USD (Dist)
Vol. in million
68,01
Percentage (%)
0,02 %
Fund
iShares MSCI USA ESG Screened UCITS ETF USD (Acc)
Vol. in million
701,77
Percentage (%)
0,02 %
Fund
iShares MSCI World ESG Screened UCITS ETF USD (Acc)
Vol. in million
191,57
Percentage (%)
0,01 %

Company Data

Name ROYALTY PHARMA PLC - CLASS A
Company Royalty Pharma plc
Symbol RPRX
Website https://www.royaltypharma.com
Primary Exchange XNAS NASDAQ
WKN A2P62D
ISIN GB00BMVP7Y09
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Sandy Balkin Ph.D.
Market Capitalization 14 Mrd.
Country United States of America
Currency USD
Employees 0,1 T
Address 110 East 59th Street, 10022 New York
IPO Date 2020-06-16
Dividends from 'ROYALTY PHARMA PLC - CLASS A'
Ex-Date Dividend per Share
16.05.2025 0,22 USD
21.02.2025 0,22 USD
15.11.2024 0,21 USD
16.08.2024 0,21 USD
16.05.2024 0,21 USD
15.02.2024 0,21 USD
16.11.2023 0,20 USD
17.08.2023 0,20 USD
18.05.2023 0,20 USD
15.02.2023 0,20 USD

Ticker Symbols

Name Symbol
Frankfurt RPD.F
NASDAQ RPRX

More Shares

Investors who ROYALTY PHARMA PLC - CLASS A hold also have the following shares in their portfolio:
AMAZON.CO INC
AMAZON.CO INC Share
AMGEN INC
AMGEN INC Share
APPLE INC
APPLE INC Share
AUTODESK INC
AUTODESK INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DS INVESTOR  ANL 22/26
DS INVESTOR ANL 22/26 Bond
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
S IMMO AG
S IMMO AG Share
SNAP INC CL.A
SNAP INC CL.A Share
STONECO LTDS A COMMON SHARE
STONECO LTDS A COMMON SHARE Share
TESLA INC
TESLA INC Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025